You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 12, December 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  NEUROLOGICAL REVIEW
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

The Molecular Genetic Revolution

Its Impact on Clinical Neurology

Cynthia S. Payne, MD; Allen D. Roses, MD

Arch Neurol. 1988;45(12):1366-1376.


Abstract

• Applying the techniques of molecular genetics to the study of inherited diseases has made significant progress in recent years. The goal of this review is to update the clinical neurologist on the current state of progress in neurogenetic research. This progress has been primarily in the field of gene mapping—assigning a disease to its chromosomal locus. More recent advances have been in the cloning and study of the involved proteins in disorders such as Duchenne muscular dystrophy. The techniques are powerful and predictable in outcome. Knowledge in the field of genetic disorders will continue to expand rapidly. Many neurologic disorders have a genetic origin. As progress continues in the study of neurogenetic diseases, the clinical neurologist will have increasing options for diagnosis and counseling. Eventually, it is anticipated that therapeutic interventions will be available for some disorders. The clinical neurologist is a key worker in both research as well as the practical application of research advances. This review will focus initially and briefly on the basic methods of molecular genetic research. After the introduction to these methods, the remainder of the review will discuss recent advances in several neurogenetic disorders that are likely to be encountered by the clinical neurologist. Gene therapy will also be briefly discussed.



Author Affiliations

From the Department of Medicine, Division of Neurology, Duke University Medical Center, Durham, NC.


Footnotes

Accepted for publication June 15, 1988.

Reprint requests to Department of Medicine, Division of Neurology, Duke University Medical Center, PO Box 2900, Durham, NC 27710 (Dr Roses).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Presymptomatic Diagnosis of Delayed-Onset Disease With Linked DNA Markers: The Experience in Huntington's Disease
Brandt et al.
JAMA 1989;261:3108-3114.
ABSTRACT  

Neurology
Joynt
JAMA 1989;261:2859-2860.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.